Non-invasive and continuous monitoring of 3D stem cell culture in a bioreactor

Abstract The development and discovery of new drugs and therapy products in regenerative medicine are carried out through multiple stages which involve several strict quality protocols. The use of cell-based model systems is the most relevant alternative to deviate from animal testing. However, the underlying biomanufacturing process in a 3D environment can be prone to failures or unexpected behaviors such as cell growth anomalies or inconsistencies in cell aggregation, which can seriously affect the quality of the result. Therefore, it is necessary to establish a non-invasive and continuous monitoring mechanism that minimizes contamination risks, allows taking early decisions and enables large-scale production in the long term. The results of our embedded machine learning approach show that it is feasible to train machine learning models that can operate on a resourcelimited embedded board with acceptable prediction accuracy for the estimation of the average size of growing stem cell spheroids. Further experiments are needed to investigate the full information potential of the recorded process data.

Authors

Institutions

Publication Details

Journal
Current Directions in Biomedical Engineering
Published
2024-12-01
DOI
https://doi.org/10.1515/cdbme-2024-2036
Citations
1
Primary Topic
3D Printing in Biomedical Research
Type
article
Field-Weighted Citation Impact
0.18
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Non-invasive and continuous monitoring of 3D stem cell culture in a bioreactor

Ina Meiser, Maira Carrillo, Saskia Altmaier, Frank R. Ihmig
1 citations
Current Directions in Biomedical Engineering
3D Printing in Biomedical Research
0.18
article

Non-invasive and continuous monitoring of 3D stem cell culture in a bioreactor

Ina Meiser, Maira Carrillo, Saskia Altmaier, Frank R. Ihmig
article en
1 citations

Abstract

Abstract The development and discovery of new drugs and therapy products in regenerative medicine are carried out through multiple stages which involve several strict quality protocols. The use of cell-based model systems is the most relevant alternative to deviate from animal testing. However, the underlying biomanufacturing process in a 3D environment can be prone to failures or unexpected behaviors such as cell growth anomalies or inconsistencies in cell aggregation, which can seriously affect the quality of the result. Therefore, it is necessary to establish a non-invasive and continuous monitoring mechanism that minimizes contamination risks, allows taking early decisions and enables large-scale production in the long term. The results of our embedded machine learning approach show that it is feasible to train machine learning models that can operate on a resourcelimited embedded board with acceptable prediction accuracy for the estimation of the average size of growing stem cell spheroids. Further experiments are needed to investigate the full information potential of the recorded process data.

Current Directions in Biomedical EngineeringVol. 10(4)
Fraunhofer Institute for Biomedical Engineering (DE), Saarland University (DE)
Openalex Percentile: Top 49%
3D Printing in Biomedical Research
0.18
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Non-invasive and continuous monitoring of 3D stem cell culture in a bioreactor — Ina Meiser, Maira Carrillo, et al. · Current Directions in Biomedical Engineering (2024) | TGRS Research Map | TGRS